Curcumin has been used to successfully treat infantile hemangioendothelioma of the liver. - GreenMedInfo Summary

Abstract Title:

Potential response to curcumin in infantile hemangioendothelioma of the liver.

Abstract Source:

Pediatr Blood Cancer. 2010 Aug;55(2):377-9. PMID: 20582974

Abstract Author(s):

Lewis A Hassell, Le Dinh Roanh

Article Affiliation:

University of Oklahoma Health Sciences Center, Oklahoma City, Oklahoma 73104, USA. [email protected]

Abstract:

A case of life-threatening infantile hemangioendothelioma of the liver in a 6-month-old infant treated successfully with the dietary supplement curcumin is reported, with 6-year follow-up. Implications for pathogenesis based on sites of action of curcumin are considered.

Article Published Date : Aug 01, 2010
Study Type : Human: Case Report
Additional Links
Substances : Curcumin : CK(7066) : AC(3242)
Diseases : Hemangioendothelioma : CK(5) : AC(2), Liver Cancer : CK(3100) : AC(1627)
Pharmacological Actions : Antineoplastic Agents : CK(2221) : AC(1456)

Print Options

Some features are currently member only features. If you are already a member, please login. Otherwise, click here to become a member.
  • Printer-friendly version

Key Research Topics

Disease

Liver Cancer
Hemangioendothelioma

Pharmacological Actions

Antineoplastic Agents

Substance

Curcumin

Connect with GreenMedInfo

This website is for information purposes only. By providing the information contained herein we are not diagnosing, treating, curing, mitigating, or preventing any type of disease or medical condition. Before beginning any type of natural, integrative or conventional treatment regimen, it is advisable to seek the advice of a licensed healthcare professional.

© Copyright 2008-2024 GreenMedInfo.com, Journal Articles copyright of original owners, MeSH copyright NLM.